Tag: luxembourg
-
GSK asthma drug Nucala’s long-term study supports safety profile
(Reuters) – GlaxoSmithKline Plc said on Saturday its asthma drug, Nucala, which is already approved in the United States and Europe, showed a similar safety profile in a long-term study compared with previous studies. GSK said Nucala, which is administered once every four weeks by injection, maintained its risk/benefit profile over an extended 52-week period.…
-
British sailors ready ‘protection package’ for Rio
By Alexander Smith LONDON (Reuters) – Obsessive hand washing, mouthwashes, downing cola after races and popping garlic tablets are just some of the precautions Britain's Olympic sailing team will be taking for the Games in Rio. With the polluted waters of Guanabara Bay a concern and the Zika virus also a worry, the athletes are…
-
Brexit is the wrong prescription, says European pharma industry
By Ben Hirschler LONDON (Reuters) – Britain's departure from the European Union would threaten scientific research and jeopardize the 28-nation bloc's system of drug regulation, the European pharmaceutical industry said on Wednesday. The declaration is the clearest statement yet on the issue by an industry that includes EU-based players such as Britain's GlaxoSmithKline and AstraZeneca,…
-
Adviser to top EU court says EU cigarette law is valid
An adviser to Europe's highest court in Luxembourg on Wednesday said an EU law on cigarettes was valid, rebuffing a challenge from Philip Morris International, although the court still has to deliver a final ruling. The opinion, if adopted by the court, would be a blow to Big Tobacco, which had lobbied vigorously against what…
-
Adviser to top EU court says EU cigarette law is valid
An adviser to Europe's highest court in Luxembourg on Wednesday said an EU law on cigarettes was valid, rebuffing a challenge from Philip Morris International, although the court still has to deliver a final ruling. The opinion, if adopted by the court, would be a blow to Big Tobacco, which had lobbied vigorously against what…
-
Drugged up: GSK, Roche and Sanofi to set out their stalls
By Ben Hirschler LONDON (Reuters) – Three of Europe's top drugmakers – GlaxoSmithKline, Roche and Sanofi – face health checks this week at high-profile presentations designed to show they can overcome looming market threats. GSK's Andrew Witty and Sanofi's new boss Olivier Brandicourt both need to demonstrate recovery potential, after recent disappointments, while Roche's Severin…